Teva Pharmaceutical reported 819M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Aspen Pharmacare APN:SJ 4.29B 232M
Cipla CIPLA:IN 8.92B 199.8M
Dr.Reddys Laboratories DRRD:IN 23.84B 810M
Guangzhou Baiy 600332:CH 2.42B 406.51M
Jiangsu Hengrui Me. 600276:CH 2.33B 1.35B
Kalbe Farma Tbk Pt KLBF:IJ 1589.07B 82.46B
Richter Gedeon RICHT:HB 40B 2.52B
Sh Fosun Pharma 600196:CH 2.86B 445.99M
Teva Pharmaceutical TEVA:IT 819M 39M